Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trial.

Richard KazibweMatthew SingletonMichael P BancksJuliana NamutebiAziz HammouMichael ShapiroJoseph Yeboah

Published in: Diabetes, obesity & metabolism (2024)

In high-risk individuals with type 2 diabetes, the use of aspirin for primary prevention was not associated with a decreased risk of incident CVD or all-cause mortality.

Keyphrases

type diabetes
low dose
cardiovascular events
cardiovascular disease
antiplatelet therapy
study protocol
clinical trial
phase iii
glycemic control
phase ii
anti inflammatory drugs
randomized controlled trial
acute coronary syndrome
metabolic syndrome